Jason C. Bermak, MD, PhD, is a board-certified psychiatrist, also with a PhD in pharmacology and toxicology. He has a private practice and additionally serves as the medical director of SF-CARE, Inc., a small clinical research center located in San Rafael. Dr. Bermak’s clinical trials are currently focused on developing novel treatments and treatment combinations for those suffering from conditions of depression, anxiety, and schizophrenia. These new treatments include the use nasal spray formulations of ketamine for depression and novel long-acting antipsychotics for psychosis.

Dr. Bermak’s clinical duties are currently outpatient focused and have, in recent years, also included institutional and inpatient positions at the California Medical Facility, Napa State Hospital, and Saint Francis Memorial Hospital. Dr. Bermak is also a partner at Anvyl Pharmaceuticals, LLC, a non-commercial biopharmaceutical company aimed at developing therapies for neurocognitive and psychiatric disorders. He has authored or coauthored more than a dozen publications stemming from his CNS and drug development-related research endeavors. He received his psychiatric residency training at the University of California, San Francisco, his MD and PhD in pharmacology at the University of California, Irvine, and a BS in Chemistry at the University of California, Berkeley.

Dr. Robin Bitner is a board-certified psychiatrist licensed to practice medicine in the state of California. Dr. Bitner received a B.A. from Bates College and a M.D. from the University of California-Irvine, both with honors. She completed residency training in General Adult Psychiatry at the University of California-San Francisco (UCSF). Dr. Bitner provides outpatient treatment with a collaborative approach using psychotherapy (psychodynamic, supportive, CBT and mindfulness-based), psychopharmacology and/or transcranial magnetic stimulation (TMS).

In addition to her outpatient practice, Dr. Bitner is currently on staff at Marin General Hospital and treats patients in the intensive outpatient programs and in the hospital (consultation and inpatient stabilization). She also currently serves as a volunteer faculty member at UCSF and is involved in teaching in the residency training program. Areas of specialty include: mood disorders (including bipolar disorder and treatment-resistant depression), anxiety disorders, attention deficit/hyperactivity disorder (ADHD), relationship issues, grief and loss, undergraduate and graduate student mental health, adjustments associated with major life transitions, stress management and women’s mental health (including perinatal and premenstrual difficulties).

John M. Cruz, M.D. is a board certified child, adolescent and adult psychiatrist. He received his Bachelor of Arts in Psychology from Dartmouth College, his post-baccalaureate pre-medical certificate from Columbia University, his medical degree from New York University School of Medicine, and completed his adult psychiatry training from The Johns Hopkins Hospital, and his child and adolescent psychiatry fellowship from The Johns Hopkins Hospital where he served as chief resident. Dr. Cruz sees children, adolescents, and adults. He treats a variety of psychiatric disorders that include: Attention Deficit Hyperactivity Disorder (ADHD), depressive disorders, anxiety disorders, disruptive and impulse-control disorders, bipolar disorders, and psychotic disorders.

Dr. Cruz is a member of the American Psychiatric Association, the American Academy of Child and Adolescent Psychiatry, the Northern California Psychiatric Society, and the Northern California Regional Organization of Child and Adolescent Psychiatry. ​Dr. Cruz became interested in TMS because, “TMS has been shown through FDA randomized controlled trials to be an extremely effective, non-invasive treatment with no systemic side effects for treating people with medication resistant depression.”

Corey Priesman, MD earned his medical degree from the University of Nebraska Medical Center and completed a residency in psychiatry at California Pacific Medical Center. He utilizes a range of therapeutic approaches including psychodynamic psychotherapy, cognitive behavioral therapy, and psychopharmacotherapy to treat a wide range of patients in his outpatient and hospital based practices.

Tammy Chin, MD graduated from the University of California San Francisco School of Medicine and also completed her psychiatry residency at UCSF. Dr. Chin provides psychopharmacology and psychotherapy treatment for patients in her outpatient practice and is excited to offer neuromodulation treatment through TMS.

Dr. Chin manages a full spectrum of mental disorders. She is particularly interested in the management of mood and anxiety disorders, cultural psychiatry, and multiple types of psychotherapy. She takes a collaborative approach in treatment planning with her patients to help her patients reach their treatment goals and improve quality of life.